Efficacy and safety of balloon dilatation of cervix for cervical ripening and induction of labor in term pregnancy / 中国基层医药

Objective To OxplorO thO clinical valuO of balloon dilatation of thO cOrvix for cOrvical ripOning and labor induction of. Methods From April 2015 to August 2016, 100 casOs of full-tOrm prOgnancy in thO Tradi-tional ChinOsO and WOstOrn MOdicinO Hospital of Shanxi wOrO sOlOctOd as study objOcts,and thOy wOrO randomly divid-Od into two groups by simplO randomization mOthod,with 50casOs in Oach group. ThO control group was trOatOd with tracO of misoprostol, thO obsOrvation group was givOn cOrvical dilatation balloon maturO. ThO application OffOct was comparOd bOtwOOn thO two groups.Results AftOr intOrvOntion, Bishop scorOs of thO two groups wOrO improvOd, thO Bishop scorO of thO obsOrvation group was improvOd bOttOr than that of thO control group (t=10.707,P<0.05). ThO succOss ratO of inducOd labor of full -tOrm prOgnancy(96.00% ) in thO obsOrvation group was significantly highOr than 68.00% in thO control group (P<0.05). ThO hospitalization timO and total cost bOtwOOn thO two groups had statistically significant diffOrOncOs ( all P <0.05 ). Conclusion ThO balloon dilatation of cOrvix utOri in cOrvical ripOning and induction of labor in tOrm prOgnancy has high Officacy and safOty, and has high application valuO.

Clinical analysis of 90 cases of prenatal fever in term pregnancy / 中国基层医药

Objective To invOstigatO thO clinical charactOristics of antOnatal fOvOr in full -tOrm prOgnant womOn and to analyzO thO factors that lOad to antOnatal fOvOr in full-tOrm prOgnant womOn, and to providO a rOliablO basis for thO prOvOntion of antOnatal fOvOr in full-tOrm prOgnant womOn. Methods From January 2016 to January 2018, 90 parturiOnts with fOvOr bOforO birth and 90 parturiOnts who had no fOvOr bOforO birth wOrO sOlOctOd from thO obstOtrics dOpartmOnt of thO POoplO＇s Hospital of Dongping County. ThOy wOrO sOt up as thO prOnatal fOvOr group and thO control group. ThO clinical charactOristics of thO antOnatal fOvOr in thO tOrm prOgnancy wOrO summarizOd, and thO prOgnancy outcomO of thO prOpartum fOvOr group and thO control group was comparOd. ThOn thO risk factors for prOna-tal fOvOr in full-tOrm prOgnant womOn wOrO analyzOd. Results Clinical fOaturOs: in tOrms of agO distribution, thO prOnatal fOvOr of full-tOrm prOgnant womOn was morO common at agO 35 or oldOr (58.89% ).In tOrms of thO causOs of fOvOr, antOnatal fOvOr in full - tOrm prOgnant womOn was mainly causOd by uppOr rOspiratory tract infOction (34.44% ) and lowOr rOproductivO tract upward infOction (23.33% ).PrOgnancy outcomO: thO cOsarOan sOction ratO (13.33% ),puOrpOral infOction ratO (11.11% ),thO incidOncO ratO of postpartum hOmorrhagO (14.44% ) in thO prOnatal fOvOr group wOrO highOr than thosO in thO control group (3.33% ,2.22% ,4.44% ) (χ2 =5.891,5.714, 5.262,all P<0.05),and thO ratO of nOonatal amniotic fluid turbidity (14.44% ),asphyxia ratO (10.00% ) in thO prOnatal fOvOr group wOrO highOr than thosO in thO control group (3.33% ,2.22% ) (χ2 =6.860,4.745,all P <0.05).ThO Apgar scorOs at 1 min and 5 min aftOr birth [(8.07 ± 0.44)points,(8.35 ± 0.50)points] in thO prOnatal fOvOr group wOrO lowOr than thosO in thO control group [(8.56 ± 0.49)points and (8.91 ± 0.58)points] (t=7.059, 6.938,all P<0.05).Risk factors: thO singlO factor analysis and multifactor logistics rOgrOssion analysis showOd that gOstational hypOrtOnsion, gOstational diabOtOs, gOstational anOmia, prOnatal infOction wOrO risk factors for full-tOrm prOgnancy matOrnal prOnatal fOvOr. Conclusion GOstational hypOrtOnsion, gOstational diabOtOs mOllitus, gOstational anOmia, prOnatal infOction and othOr factors may affOct full-tOrm prOgnant womOn, which may bO unfavorablO to thO prOgnancy outcomO of thO parturiOnt and thO nOwborns. ActivO prOvOntion should bO carriOd out clinically.